CN1751676B - 一种中药的膜超滤精制方法 - Google Patents
一种中药的膜超滤精制方法 Download PDFInfo
- Publication number
- CN1751676B CN1751676B CN 200410072060 CN200410072060A CN1751676B CN 1751676 B CN1751676 B CN 1751676B CN 200410072060 CN200410072060 CN 200410072060 CN 200410072060 A CN200410072060 A CN 200410072060A CN 1751676 B CN1751676 B CN 1751676B
- Authority
- CN
- China
- Prior art keywords
- ultrafiltration
- pressure
- membrane
- film
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000108 ultra-filtration Methods 0.000 title claims abstract description 461
- 239000003814 drug Substances 0.000 title claims abstract description 91
- 238000007670 refining Methods 0.000 title abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 178
- 239000012528 membrane Substances 0.000 claims abstract description 115
- 238000000034 method Methods 0.000 claims abstract description 84
- 230000008569 process Effects 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 158
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 147
- 238000011001 backwashing Methods 0.000 claims description 126
- 239000000706 filtrate Substances 0.000 claims description 110
- 239000000243 solution Substances 0.000 claims description 78
- 235000015073 liquid stocks Nutrition 0.000 claims description 45
- 239000011550 stock solution Substances 0.000 claims description 45
- 238000000429 assembly Methods 0.000 claims description 42
- 230000000712 assembly Effects 0.000 claims description 42
- 230000000737 periodic effect Effects 0.000 claims description 38
- 229920002492 poly(sulfone) Polymers 0.000 claims description 24
- 229920001747 Cellulose diacetate Polymers 0.000 claims description 23
- 238000001914 filtration Methods 0.000 claims description 21
- 238000000605 extraction Methods 0.000 claims description 19
- 229920006393 polyether sulfone Polymers 0.000 claims description 15
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 12
- 239000002033 PVDF binder Substances 0.000 claims description 11
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- 229920002301 cellulose acetate Polymers 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000004695 Polyether sulfone Substances 0.000 claims description 7
- 239000012567 medical material Substances 0.000 claims description 7
- 239000011261 inert gas Substances 0.000 claims description 6
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 claims description 6
- 238000001471 micro-filtration Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000008394 flocculating agent Substances 0.000 claims description 4
- 229910052756 noble gas Inorganic materials 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- KXJGSNRAQWDDJT-UHFFFAOYSA-N 1-acetyl-5-bromo-2h-indol-3-one Chemical compound BrC1=CC=C2N(C(=O)C)CC(=O)C2=C1 KXJGSNRAQWDDJT-UHFFFAOYSA-N 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 238000005352 clarification Methods 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 229920001721 polyimide Polymers 0.000 claims description 3
- 230000013872 defecation Effects 0.000 claims description 2
- 238000000151 deposition Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000007493 shaping process Methods 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 description 165
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 132
- 239000000126 substance Substances 0.000 description 125
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 54
- 238000005516 engineering process Methods 0.000 description 51
- 239000002994 raw material Substances 0.000 description 42
- 238000011010 flushing procedure Methods 0.000 description 41
- 230000007935 neutral effect Effects 0.000 description 41
- 239000000843 powder Substances 0.000 description 36
- 239000002671 adjuvant Substances 0.000 description 34
- 241000180649 Panax notoginseng Species 0.000 description 32
- 235000003143 Panax notoginseng Nutrition 0.000 description 32
- 241000628997 Flos Species 0.000 description 30
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 30
- 239000000284 extract Substances 0.000 description 28
- 229910052757 nitrogen Inorganic materials 0.000 description 27
- 238000009423 ventilation Methods 0.000 description 27
- 239000000341 volatile oil Substances 0.000 description 26
- 239000005708 Sodium hypochlorite Substances 0.000 description 25
- 239000011259 mixed solution Substances 0.000 description 25
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 25
- 238000001035 drying Methods 0.000 description 24
- 239000006187 pill Substances 0.000 description 24
- 239000006228 supernatant Substances 0.000 description 22
- 238000002156 mixing Methods 0.000 description 21
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 20
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 20
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 18
- 108090000862 Ion Channels Proteins 0.000 description 18
- 102000004310 Ion Channels Human genes 0.000 description 18
- 239000008187 granular material Substances 0.000 description 18
- 239000003921 oil Substances 0.000 description 16
- 235000019359 magnesium stearate Nutrition 0.000 description 15
- 239000000463 material Substances 0.000 description 14
- 230000008859 change Effects 0.000 description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 12
- 239000004744 fabric Substances 0.000 description 12
- 239000008101 lactose Substances 0.000 description 12
- 238000009495 sugar coating Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 210000000582 semen Anatomy 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 239000009636 Huang Qi Substances 0.000 description 9
- 244000131316 Panax pseudoginseng Species 0.000 description 9
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 8
- 241000736148 Styrax Species 0.000 description 8
- 239000004870 Styrax Substances 0.000 description 8
- 235000000126 Styrax benzoin Nutrition 0.000 description 8
- 235000008504 concentrate Nutrition 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 229940057995 liquid paraffin Drugs 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 206010002383 Angina Pectoris Diseases 0.000 description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000002386 leaching Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000008108 microcrystalline cellulose Substances 0.000 description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 235000008434 ginseng Nutrition 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229960004793 sucrose Drugs 0.000 description 6
- 241000756943 Codonopsis Species 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 5
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 5
- 229960003321 baicalin Drugs 0.000 description 5
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 235000002949 phytic acid Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- 241000209020 Cornus Species 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 4
- 239000004383 Steviol glycoside Substances 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229940068041 phytic acid Drugs 0.000 description 4
- 239000000467 phytic acid Substances 0.000 description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 4
- 239000004299 sodium benzoate Substances 0.000 description 4
- 235000010234 sodium benzoate Nutrition 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 229930182488 steviol glycoside Natural products 0.000 description 4
- 235000019411 steviol glycoside Nutrition 0.000 description 4
- 150000008144 steviol glycosides Chemical class 0.000 description 4
- 235000019202 steviosides Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- -1 flavone glycoside Chemical class 0.000 description 3
- 238000005243 fluidization Methods 0.000 description 3
- 238000000703 high-speed centrifugation Methods 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 2
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 2
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 241001057584 Myrrha Species 0.000 description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
- 239000000006 Nitroglycerin Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004353 Polyethylene glycol 8000 Substances 0.000 description 2
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000005267 amalgamation Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- RSMSFENOAKAUJU-UHFFFAOYSA-L bis[[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy]aluminum;hydrate Chemical compound O.C=1C=C(Cl)C=CC=1OC(C)(C)C(=O)O[Al]OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 RSMSFENOAKAUJU-UHFFFAOYSA-L 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000008395 clarifying agent Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 229960003711 glyceryl trinitrate Drugs 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229940085678 polyethylene glycol 8000 Drugs 0.000 description 2
- 235000019446 polyethylene glycol 8000 Nutrition 0.000 description 2
- 239000009286 sanguis draxonis Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 238000007560 sedimentation technique Methods 0.000 description 2
- 235000020374 simple syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- 241000242759 Actiniaria Species 0.000 description 1
- 206010002388 Angina unstable Diseases 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000007718 Stable Angina Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000007814 Unstable Angina Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000005493 condensed matter Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 239000008899 fufang danshen Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960003371 protocatechualdehyde Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410072060 CN1751676B (zh) | 2004-09-22 | 2004-09-22 | 一种中药的膜超滤精制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410072060 CN1751676B (zh) | 2004-09-22 | 2004-09-22 | 一种中药的膜超滤精制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1751676A CN1751676A (zh) | 2006-03-29 |
CN1751676B true CN1751676B (zh) | 2010-04-28 |
Family
ID=36678755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410072060 Expired - Fee Related CN1751676B (zh) | 2004-09-22 | 2004-09-22 | 一种中药的膜超滤精制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1751676B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101632695B (zh) * | 2008-07-24 | 2011-06-08 | 劲牌有限公司 | 利用超滤膜分离怀牛膝提取液中活性成分的方法 |
CN101531721B (zh) * | 2009-04-28 | 2011-07-20 | 中国药科大学 | 一种三萜皂苷单体的工业化制备方法 |
CN102020687B (zh) * | 2009-09-18 | 2012-06-13 | 劲牌有限公司 | 从党参中提取分离党参炔苷的方法 |
CN104099207A (zh) * | 2013-04-10 | 2014-10-15 | 安徽先求药业有限公司 | 适用于健力补酒的超滤分离技术 |
CN104958336A (zh) * | 2015-07-08 | 2015-10-07 | 成都易胜科生物科技有限公司 | 一种超滤和纳滤技术相结合的三七总皂苷提纯方法 |
CN107824049A (zh) * | 2017-11-13 | 2018-03-23 | 安徽名创新材料科技有限公司 | 一种剪切技术强化膜分离过程的方法 |
CN108607017A (zh) * | 2018-06-08 | 2018-10-02 | 辽宁仙草堂药业有限公司 | 一种枣仁安神液的制备方法 |
CN109481498A (zh) * | 2018-12-25 | 2019-03-19 | 佛山科学技术学院 | 一种治疗酒精急性中毒的针剂 |
CN113100608B (zh) * | 2021-05-14 | 2022-07-12 | 付常青 | 一种用于文物展览的保存方法及其展览框 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1449778A (zh) * | 2002-04-09 | 2003-10-22 | 深圳太太药业有限公司 | 一种具有治疗痛经作用及美容作用的中药组合物 |
CN1476892A (zh) * | 2003-07-28 | 2004-02-25 | 范兆科 | 膜技术分离中药有效成份的方法 |
-
2004
- 2004-09-22 CN CN 200410072060 patent/CN1751676B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1449778A (zh) * | 2002-04-09 | 2003-10-22 | 深圳太太药业有限公司 | 一种具有治疗痛经作用及美容作用的中药组合物 |
CN1476892A (zh) * | 2003-07-28 | 2004-02-25 | 范兆科 | 膜技术分离中药有效成份的方法 |
Non-Patent Citations (3)
Title |
---|
韩丽.实用中药制剂新技术 1.化学工业出版社,2002,第209页实例1, 第208页第10行. |
韩丽.实用中药制剂新技术 1.化学工业出版社,2002,第209页实例1, 第208页第10行. * |
韩丽.应用逆流提取与膜分离技术的中药注射剂新工艺研究-丹参粉针工艺研究.中国博士学位论文全文数据库.2003,第46页倒数第5行-倒数第3行, 第42页第13行-第15行、表40. * |
Also Published As
Publication number | Publication date |
---|---|
CN1751676A (zh) | 2006-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101085071B (zh) | 含有丹参、山楂的中药组合物及其制剂 | |
CN101085012B (zh) | 一种含红花治疗心血管疾病的组合物及其制剂 | |
CN101085024A (zh) | 含有丹参、银杏叶的中药组合物及其制剂 | |
CN1751676B (zh) | 一种中药的膜超滤精制方法 | |
CN101084986B (zh) | 含有三七、葛根的中药组合物及其制剂 | |
CN101085064B (zh) | 一种含赤芍治疗心血管疾病的组合物及其制剂 | |
CN101085027B (zh) | 含有丹参、葛根的中药组合物及其制剂 | |
CN101085006A (zh) | 一种含葛根治疗心血管疾病的组合物及其制剂 | |
CN101085047A (zh) | 一种含何首乌治疗心血管疾病的组合物及其制剂 | |
CN1778340B (zh) | 一种治疗冠心病心绞痛的中药组合物 | |
CN101084996B (zh) | 含有丹参的中药组合物及其制剂 | |
CN101085070B (zh) | 含有三七、山楂的中药组合物及其制剂 | |
CN1751705B (zh) | 一种含丹参的中药制剂 | |
CN1751704B (zh) | 一种含丹参的中药注射剂 | |
CN101085008A (zh) | 一种含刺五加治疗心血管疾病的组合物及其制剂 | |
CN1778335B (zh) | 一种治疗冠心病心绞痛的中药 | |
CN1751675B (zh) | 一种中药复方注射剂的制备方法 | |
CN101084957A (zh) | 一种含三七、盐肤木治疗心血管疾病的组合物及其制剂 | |
CN101085010A (zh) | 一种含盐肤木治疗心血管疾病的组合物及其制剂 | |
CN101085081A (zh) | 一种含枳壳治疗心血管疾病的组合物及其制剂 | |
CN1778333B (zh) | 治疗冠心病心绞痛的中药 | |
CN1778342B (zh) | 一种治疗冠心病的中药组合物 | |
CN1778338B (zh) | 治疗冠心病心绞痛的中药组合物 | |
CN101084960B (zh) | 含有三七的中药组合物及其制剂 | |
CN1778337B (zh) | 一种复方丹参片的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARM. CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee before: TIANJIN TASLY PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100428 Termination date: 20210922 |
|
CF01 | Termination of patent right due to non-payment of annual fee |